VA
VMD icon

Vident Advisory’s Viemed Healthcare VMD Stock Holding History

Vident Advisory’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Buy
+11,146
New +$110K ﹤0.01% 1869

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Vident Advisory's VMD Position: Q2 2026 in Review

Vident Advisory opened a new position in Viemed Healthcare (VMD) in Q2 2026: 11,146 shares worth $127K. The stake represents ﹤0.01% of the portfolio and ranks #1869 among its holdings.

166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Vident Advisory held 11,146 shares of Viemed Healthcare worth $127K as of Q2 2026.
  • Viemed Healthcare was a new Vident Advisory position in Q2 2026.
  • Viemed Healthcare made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1869 holding.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.